Frankfurt - Delayed Quote EUR

Egetis Therapeutics AB (publ) (P0F.F)

0.2955

-0.0145

(-4.68%)

At close: April 15 at 9:00:34 PM GMT+2

Egetis Therapeutics AB (FRA:P0F) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline ...

Despite a drop in revenue, Egetis Therapeutics AB (FRA:P0F) strengthens its market position with key approvals and financial maneuvers.

GuruFocus.com last month

P0F.F
-4.68%
Egetis Therapeutics to Feature MCT8 Deficiency on Behind the Mystery Airing on Lifetime in Honor of Rare Disease Day

STOCKHOLM, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (Nasdaq Stockholm: EGTX), an innovative pharmaceutical company specializing in late-stage development and commercialization of treatments for serious diseases with significant unmet medical needs in the orphan drug segment will be featured on Behind the Mystery™, a TV series in the U.S. that airs on the morning talk show The Balancing Act®. Sponsored by Egetis, this episode will raise awareness

GlobeNewswire last month

EGTX.ST
Exploring Three Swedish Exchange Growth Companies With High Insider Ownership

As global markets navigate through mixed economic signals, Sweden's market remains a focal point for investors looking for growth opportunities. This context sets the stage to explore three Swedish growth companies with high insider ownership, which often indicates confidence from those closest to the company's operations and future prospects.

Simply Wall St. 9 months ago

ATT.ST

EGTX.ST

SECT-B.ST
Swedish Growth Leaders With High Insider Stakes June 2024

As global markets experience mixed signals with regions showing varied economic data, Sweden's market remains a point of interest for investors looking for growth opportunities. In this environment, companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those closest to the business in its growth prospects and governance.

Simply Wall St. 9 months ago

CTT.ST

EGTX.ST

SECT-B.ST

Performance Overview

Return	P0F.F	OMX Stockholm 30 Index (^OMX)
YTD	-49.83%	-3.72%
1-Year	-42.06%	-5.26%
3-Year	-42.03%	+14.23%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Egetis Therapeutics AB (publ) (P0F.F)

Egetis Therapeutics AB (FRA:P0F) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline ...

Egetis Therapeutics to Feature MCT8 Deficiency on Behind the Mystery Airing on Lifetime in Honor of Rare Disease Day

Exploring Three Swedish Exchange Growth Companies With High Insider Ownership

Swedish Growth Leaders With High Insider Stakes June 2024

Performance Overview